Syros

$9.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.05 (+12.50%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Syros and other stocks, options, and ETFs commission-free!

About SYRS

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425 and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA. The listed name for SYRS is Syros Pharmaceuticals, Inc. Common Stock.

CEO
Nancy A. Simonian
Employees
83
Headquarters
Cambridge, Massachusetts
Founded
2011
Market Cap
601.76M
Price-Earnings Ratio
Dividend Yield
Average Volume
738.83K
High Today
$9.75
Low Today
$8.72
Open Price
$8.90
Volume
824.93K
52 Week High
$15.65
52 Week Low
$4.26

SYRS Earnings

-$0.48
-$0.32
-$0.16
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Available Mar 4, Pre-Market

You May Also Like

GRUB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure